Impact of type of thrombolytic agent on in-hospital outcomes in ST-segment elevation myocardial infarction patients in the Middle East.
Al-Zakwani, Ibrahim
Impact of type of thrombolytic agent on in-hospital outcomes in ST-segment elevation myocardial infarction patients in the Middle East. [electronic resource] - Journal of thrombosis and thrombolysis Apr 2012 - 280-6 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1573-742X
10.1007/s11239-012-0698-6 doi
Adult
Aged
Female
Fibrinolytic Agents--classification
Hospital Mortality--trends
Hospitalization--trends
Humans
Internationality
Male
Middle Aged
Middle East--epidemiology
Myocardial Infarction--drug therapy
Prospective Studies
Recombinant Proteins--therapeutic use
Registries
Tenecteplase
Tissue Plasminogen Activator--therapeutic use
Treatment Outcome
Impact of type of thrombolytic agent on in-hospital outcomes in ST-segment elevation myocardial infarction patients in the Middle East. [electronic resource] - Journal of thrombosis and thrombolysis Apr 2012 - 280-6 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1573-742X
10.1007/s11239-012-0698-6 doi
Adult
Aged
Female
Fibrinolytic Agents--classification
Hospital Mortality--trends
Hospitalization--trends
Humans
Internationality
Male
Middle Aged
Middle East--epidemiology
Myocardial Infarction--drug therapy
Prospective Studies
Recombinant Proteins--therapeutic use
Registries
Tenecteplase
Tissue Plasminogen Activator--therapeutic use
Treatment Outcome